Cholestatic jaundice induced by duloxetine in a patient with major depressive disorder

about

Duloxetine-induced liver injury in patients with major depressive disorder.Duloxetine in affective disorders: a naturalistic study on psychiatric and medical comorbidity, use in association and tolerability across different age groups Acute dystonia after using single dose duloxetine: case report.

P2860

Q35238358-EA0DCA4E-EC96-42A0-A028-2C36080263E2 Q36395440-97B0133A-551A-41A6-960D-827D2A72349F Q36662919-F45AD6CD-0BE2-4B86-9DB6-0F3FE91DDE1C

P2860

Cholestatic jaundice induced by duloxetine in a patient with major depressive disorder

Item

http://www.wikidata.org/entity/Q42013874

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Cholestatic jaundice induced by duloxetine in a patient with major depressive disorder

@en

Cholestatic jaundice induced by duloxetine in a patient with major depressive disorder

@nl

type

Item

label

Cholestatic jaundice induced by duloxetine in a patient with major depressive disorder

@en

Cholestatic jaundice induced by duloxetine in a patient with major depressive disorder

@nl

prefLabel

Cholestatic jaundice induced by duloxetine in a patient with major depressive disorder

@en

Cholestatic jaundice induced by duloxetine in a patient with major depressive disorder

@nl

P1476

Cholestatic jaundice induced by duloxetine in a patient with major depressive disorder

@en

P2093

Bun-Hee Lee

http://www.w3.org/2001/XMLSchema#string

Heon-Jeong Lee

http://www.w3.org/2001/XMLSchema#string

Seung-Gul Kang

http://www.w3.org/2001/XMLSchema#string

Young-Min Park

http://www.w3.org/2001/XMLSchema#string

P2860

Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials.

Hepatic effects of duloxetine-I: non-clinical and clinical trial data.

Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States.

Antidepressant-induced hepatotoxicity.

Mechanisms of drug-induced liver injury.

Drug-induced liver injury: Hy's rule revisited.

Drug-induced liver injury: review article.

Answers to the most common questions about the hepatic safety profile of duloxetine.

Hepatic effects of duloxetine-II: spontaneous reports and epidemiology of hepatic events.

Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study.

P304

228-230

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.4306/PI.2010.7.3.228

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47358093

http://www.w3.org/2001/XMLSchema#string

P698

20927314

http://www.w3.org/2001/XMLSchema#string

P932

2947813

http://www.w3.org/2001/XMLSchema#string

Cholestatic jaundice induced by duloxetine in a patient with major depressive disorder

about

P2860

P2860

Cholestatic jaundice induced by duloxetine in a patient with major depressive disorder

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932